Come up with a name for your new list and we'll add to it:
SolaranRx raised a round of funding on May 02, 2015. Investors include
STC.UNM Co-Investment Fund.
SolaranRx is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics-often referred to as therano…